We examined effects of OM-X as an adjunct in the treatment of severe pneumonia. The test subjects were 76 infants, 6-24 months old with severe pneumonia.  

In the OM-X + antibiotic (low amount) administered group, average number of days taken until alleviation of coughing and hospitalization remarkably reduced in comparison with the other group with administration of regular antibiotics. These results showed that OM-X is effective in reducing pneumonia symptoms. This achievement suggests that OM-X may be able to be an alternative of antibacterial agent.